Cetirizine Hydrochloride Allergy

(cetirizine dihydrochloride (rescue medication))

PreclinicalSmall molecule

Cetirizine Hydrochloride Allergy is one of 26 small molecule programs targeting Seasonal Allergic Rhinitis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

FDA Applications

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

Seasonal Allergic RhinitisActive, not recruiting

Seasonal Allergic RhinitisPreclinical

Active, not recruiting

Competition

Competitive Landscape

25 competitors in Seasonal Allergic Rhinitis

#DrugCompanyPhaseTrials

Zyrtec

KKenvue Brands

Approved

7 2

Allegra

CChattem

Approved

7 3

Clarinex

OOrganon and Co

Approved

7 4

Flovent

PParatek Pharmaceuticals Inc

Approved

7 5

Claritin

PPerrigo Company

Approved

4 6

Asmanex Hfa

PPerrigo Company

Approved

3 7

Singulair

OOrganon and Co

Approved

3 8

Xyzal

CChattem

Approved

2 9

Kenalog

BBausch Health Americas, Inc.

Approved

—10

Adrenaline

SSamson Clinical Operations Pty Ltd

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Seasonal Allergic Rhinitis1 trial

Acupuncture for Seasonal Allergic Rhinitis

Completed·—·N/A·NCT00610584·422 enrolled

Regulatory

FDA Approval Timeline[4]

Sep 27, 1996

ZYRTEC

NDA NDA020346

Nov 16, 2007

ZYRTEC ALLERGY

NDA NDA019835

Nov 16, 2007

CHILDREN'S ZYRTEC ALLERGY

NDA NDA022155

Jul 23, 2009

CETIRIZINE HYDROCHLORIDE ALLERGY

NDA NDA022429

Sep 3, 2010

ZYRTEC ALLERGY

NDA NDA022578

May 30, 2017

ZERVIATE

NDA NDA208694

Oct 4, 2019

QUZYTTIR

NDA NDA211415

Nov 30, 2020

CHILDREN'S ZYRTEC ALLERGY

NDA NDA021621

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for cetirizine dihydrochloride (rescue medication). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — cetirizine dihydrochloride (rescue medication) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for cetirizine dihydrochloride (rescue medication). EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA021621). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Kenvue Brands company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: KKenvue Brands

Cetirizine Hydrochloride Allergy

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Seasonal Allergic Rhinitis1 trial

FDA Approval Timeline[4]

References

Drug Info

Quick Facts

Related News